4//SEC Filing
MOORE ALISON 4
Accession 0001593968-23-000492
CIK 0001737287other
Filed
Mar 15, 8:00 PM ET
Accepted
Mar 16, 4:49 PM ET
Size
5.6 KB
Accession
0001593968-23-000492
Insider Transaction Report
Form 4
MOORE ALISON
Chief Technical Officer
Transactions
- Tax Payment
Common Stock
2023-03-14$5.51/sh−8,351$45,990→ 114,637 total
Footnotes (3)
- [F1]Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.49 to $5.515, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
- [F3]Includes 558 and 2000 share of the Issuer's common stock acquired by the reporting person on September 15, 2021 and on March 15, 2023 pursuant to an employee stock purchase program, respectively.
Documents
Issuer
Allogene Therapeutics, Inc.
CIK 0001737287
Entity typeother
Related Parties
1- filerCIK 0001754937
Filing Metadata
- Form type
- 4
- Filed
- Mar 15, 8:00 PM ET
- Accepted
- Mar 16, 4:49 PM ET
- Size
- 5.6 KB